Oliver Yoa-Pu Hu

Title: Innovations by Oliver Yoa-Pu Hu: A Pioneer in Transdermal Delivery Systems

Introduction

Oliver Yoa-Pu Hu, an inventive force based in Taipei, Taiwan, has made significant contributions to the field of pharmaceutical development. With a total of four patents to his name, he has focused particularly on transdermal delivery systems that enhance the efficacy of antiviral and analgesic medications. His innovative approaches involve unique combinations of traditional Chinese medicine and modern pharmaceutical practices.

Latest Patents

Among his latest inventions is the **Acyclovir Transdermal Delivery System**. This patent describes a transdermal formulation that aims to provide antiviral effects in the dermis or epidermis. The formulation consists of 0.01 to 30 weight percent of antiviral drugs, including Acyclovir and a range of others. Additionally, it incorporates 0.05 to 20 weight percent of a Chinese medicine enhancer, preferably oleanolic acid, combined with pharmaceutical acceptable vehicles like polyethylene glycols. This innovative approach facilitates effective delivery and therapeutic efficacy of antiviral agents.

Another notable patent from Hu is concerning the **Transdermal Delivery of Buprenorphine Preparations**. Buprenorphine, known for its potent analgesic effects, has been formulated for transdermal delivery, offering an alternative route for pain management without the high risks of addiction associated with traditional narcotics. His formulation employs pure components of Chinese herbs as penetration enhancers, significantly improving the drug’s efficacy through the skin. Studies demonstrated that with a transdermal preparation containing 10% of terpineol, 15 mg of buprenorphine could be delivered through a 10 cm² skin area within 48 hours, showcasing practical application in clinical settings.

Career Highlights

Oliver Hu has worked diligently with the National Science Council, contributing to groundbreaking research and development in the field of transdermal systems. His work has not only focused on innovative drug delivery methods but has also aimed to bridge the gap between Eastern and Western medicinal practices.

Collaborations

Throughout his career, Hu has collaborated with notable colleagues, including Hui-Po Wang and Jia-Shuai Lee. These collaborations have fostered an environment for creative solutions and have advanced research in pharmaceutical sciences.

Conclusion

Oliver Yoa-Pu Hu exemplifies the spirit of innovation in pharmaceutical development. His work on transdermal delivery systems not only advances medical science but also demonstrates an integration of traditional knowledge with contemporary technology. With his unique patents, Hu is poised to continue making impactful contributions to the field of medicine.